ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993

Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level

July 2, 1999

Armand Hammer Panel chairman; DeVita Announces Greenwald Appointment; Adamson To Be DCCP Director

October 9, 1981

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986